$HCTI
Healthcare Triangle, Inc.

2022 Q3 Form 10-Q Financial Statement

#000160706222000489 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $11.95M $11.59M $11.06M
YoY Change 47.93% 15.3% 39.02%
Cost Of Revenue $8.522M $8.429M $8.162M
YoY Change 59.24% 25.73% 41.39%
Gross Profit $3.428M $3.159M $2.894M
YoY Change 25.72% -5.59% 32.74%
Gross Profit Margin 28.69% 27.26% 26.18%
Selling, General & Admin $3.295M $3.102M $3.091M
YoY Change 58.28% 67.4% 60.31%
% of Gross Profit 96.12% 98.2% 106.81%
Research & Development $1.471M $646.0K $1.066M
YoY Change -33.26% -20.54% 40.77%
% of Gross Profit 42.91% 20.45% 36.83%
Depreciation & Amortization $909.0K $844.0K $711.0K
YoY Change 330.13% 299.41% 237.53%
% of Gross Profit 26.52% 26.72% 24.57%
Operating Expenses $5.675M $4.592M $4.868M
YoY Change 26.19% 59.56% 68.09%
Operating Profit -$2.247M -$1.433M -$1.974M
YoY Change 26.91% -405.54% 175.73%
Interest Expense -$55.00K $58.00K -$16.00K
YoY Change -75.07% -64.63% -83.17%
% of Operating Profit
Other Income/Expense, Net $0.00 $1.029M
YoY Change -727.44%
Pretax Income -$2.302M -$404.0K -$1.990M
YoY Change 15.61% -232.46% 145.37%
Income Tax $37.00K $1.000K $21.00K
% Of Pretax Income
Net Earnings -$2.339M -$405.0K -$2.011M
YoY Change 17.42% -233.22% 147.02%
Net Earnings / Revenue -19.57% -3.49% -18.19%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$64.93K -$0.01 -$56.64K
COMMON SHARES
Basic Shares Outstanding 39.47M shares 35.48M shares
Diluted Shares Outstanding 36.02M shares 35.48M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.144M $1.363M $1.562M
YoY Change 260.84% -12.06%
Cash & Equivalents $4.144M $1.363M $1.562M
Short-Term Investments
Other Short-Term Assets $233.0K $668.0K $1.393M
YoY Change -66.3% 26.52%
Inventory
Prepaid Expenses
Receivables $6.702M $6.547M $6.739M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.08M $8.578M $9.694M
YoY Change 30.14% -16.1%
LONG-TERM ASSETS
Property, Plant & Equipment $76.00K $81.00K $219.0K
YoY Change 46.69% 73.63%
Goodwill $1.289M $1.289M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.79M $13.81M $12.57M
YoY Change 378.94% 348.5%
TOTAL ASSETS
Total Short-Term Assets $11.08M $8.578M $9.694M
Total Long-Term Assets $13.79M $13.81M $12.57M
Total Assets $24.86M $22.39M $22.27M
YoY Change 118.28% 68.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.468M $1.270M $1.577M
YoY Change -44.23% -47.96%
Accrued Expenses $41.00K $86.00K $132.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.453M $3.212M $2.778M
YoY Change -18.81% 6.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.060M $6.056M $7.768M
YoY Change -41.73% -31.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.227M $2.227M
YoY Change
Total Long-Term Liabilities $2.227M $2.227M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.060M $6.056M $7.768M
Total Long-Term Liabilities $2.227M $2.227M $0.00
Total Liabilities $7.287M $8.283M $7.768M
YoY Change -16.08% -6.5%
SHAREHOLDERS EQUITY
Retained Earnings -$7.419M -$5.080M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.58M $14.11M $14.50M
YoY Change
Total Liabilities & Shareholders Equity $24.86M $22.39M $22.27M
YoY Change 118.28% 68.3%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.339M -$405.0K -$2.011M
YoY Change 17.42% -233.22% 147.02%
Depreciation, Depletion And Amortization $909.0K $844.0K $711.0K
YoY Change 330.13% 299.41% 237.53%
Cash From Operating Activities -$974.0K $300.0K $302.0K
YoY Change 148.86% -121.01% -114.67%
INVESTING ACTIVITIES
Capital Expenditures -$1.283M -$2.002M -$20.00K
YoY Change 12527.95% 4881.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.283M -$2.002M -$20.00K
YoY Change 12527.95% 4881.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.038M 1.503M -490.0K
YoY Change 319687.23% -113.34%
NET CHANGE
Cash From Operating Activities -974.0K 300.0K 302.0K
Cash From Investing Activities -1.283M -2.002M -20.00K
Cash From Financing Activities 5.038M 1.503M -490.0K
Net Change In Cash 2.781M -199.0K -208.0K
YoY Change -792.58% -86.44%
FREE CASH FLOW
Cash From Operating Activities -$974.0K $300.0K $302.0K
Capital Expenditures -$1.283M -$2.002M -$20.00K
Free Cash Flow $309.0K $2.302M $322.0K
YoY Change -181.06% -265.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Other Income
OtherIncome
usd
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
us-gaap Other Income
OtherIncome
usd
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39466671 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1363000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1770000 usd
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6547000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9672000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
668000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
362000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
8578000 usd
CY2022Q2 HCTI Business Combination Working Capital
BusinessCombinationWorkingCapital
usd
CY2021Q4 HCTI Other Income Loan Forgiveness
OtherIncomeLoanForgiveness
usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11804000 usd
CY2022Q2 HCTI Fair Value Of Warrant
FairValueOfWarrant
usd
CY2022Q2 HCTI Deferredtaxassetnetofvaluationallowance
Deferredtaxassetnetofvaluationallowance
usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81000 usd
CY2021Q4 HCTI Deferredtaxassetnetofvaluationallowance
Deferredtaxassetnetofvaluationallowance
usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40903
dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE TRIANGLE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3559776
dei Entity Address Address Line1
EntityAddressAddressLine1
7901 Stoneridge Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
dei Entity Address City Or Town
EntityAddressCityOrTown
Pleasanton
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94588
dei City Area Code
CityAreaCode
(925)
dei Local Phone Number
LocalPhoneNumber
270-4812
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
usd
HCTI Esop Exercised
EsopExercised
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
HCTI Increase In Paycheck Protection Program Loan
IncreaseInPaycheckProtectionProgramLoan
usd
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Central Index Key
EntityCentralIndexKey
0001839285
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 HCTI Payroll Protection Program Loan
PayrollProtectionProgramLoan
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
CY2022Q2 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2021Q2 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
HCTI Income From Ppp
IncomeFromPpp
usd
HCTI Warrant Fair Valuation Expenses
WarrantFairValuationExpenses
usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
usd
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
dei Trading Symbol
TradingSymbol
HCTI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11005000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10458000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
1289000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
1289000 usd
CY2022Q2 us-gaap Due From Affiliates
DueFromAffiliates
1350000 usd
CY2021Q4 us-gaap Due From Affiliates
DueFromAffiliates
816000 usd
CY2022Q2 us-gaap Assets
Assets
22389000 usd
CY2021Q4 us-gaap Assets
Assets
24613000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1270000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1873000 usd
CY2022Q2 HCTI Warrant Liability
WarrantLiability
55000 usd
CY2021Q4 HCTI Warrant Liability
WarrantLiability
55000 usd
CY2021Q4 HCTI Payroll Protection Program Loan
PayrollProtectionProgramLoan
1069000 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
3212000 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2209000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
86000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
176000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1433000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
869000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6056000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6251000 usd
CY2022Q2 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
2227000 usd
CY2021Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
2227000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
8283000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8478000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 HCTI Preferred Stock Voting Shares
PreferredStockVotingShares
6000 shares
CY2021Q4 HCTI Preferred Stock Voting Shares
PreferredStockVotingShares
6000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35536671 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35536671 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35260834 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35260834 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19186000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18799000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5080000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2664000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14106000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16135000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
305000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2394000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22389000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24613000 usd
CY2022Q2 us-gaap Revenues
Revenues
11588000 usd
CY2021Q2 us-gaap Revenues
Revenues
10050000 usd
us-gaap Revenues
Revenues
22644000 usd
us-gaap Revenues
Revenues
18003000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
8429000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
6704000 usd
us-gaap Cost Of Revenue
CostOfRevenue
16591000 usd
us-gaap Cost Of Revenue
CostOfRevenue
12477000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
646000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
813000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1712000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1571000 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1651000 usd
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
805000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3391000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1473000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1451000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1048000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2802000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2308000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
844000 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
211000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1555000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
422000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
4592000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2878000 usd
us-gaap Operating Expenses
OperatingExpenses
9460000 usd
us-gaap Operating Expenses
OperatingExpenses
5774000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1433000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
469000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3407000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-248000 usd
CY2022Q2 us-gaap Other Income
OtherIncome
1087000 usd
us-gaap Other Income
OtherIncome
1087000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
58000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
164000 usd
us-gaap Interest Expense
InterestExpense
74000 usd
us-gaap Interest Expense
InterestExpense
259000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1029000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1013000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-259000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-404000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-507000 usd
CY2022Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1000 usd
us-gaap Net Income Loss
NetIncomeLoss
-511000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1555000 usd
CY2021Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1000 usd
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
22000 usd
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
4000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-405000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
304000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2416000 usd
us-gaap Net Income Loss
NetIncomeLoss
-511000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35484290 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29579405 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35484290 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29579405 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35484290 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29579405 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35484290 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29579405 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14499000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-405000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14106000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4095000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
32000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
304000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4445000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16135000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 usd
HCTI Cash Collected On Common Stock Options
CashCollectedOnCommonStockOptions
10000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
350000 usd
us-gaap Profit Loss
ProfitLoss
-2416000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
14106000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4328000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
600000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000 usd
us-gaap Profit Loss
ProfitLoss
-511000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3486000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
4445000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2416000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
422000 usd
HCTI Income From Ppp
IncomeFromPpp
1069000 usd
HCTI Common Stock Issued For Services
CommonStockIssuedForServices
350000 usd
HCTI Common Stock Issued For Services
CommonStockIssuedForServices
599000 usd
HCTI Warrant Fair Valuation Expenses
WarrantFairValuationExpenses
55000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3125000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
432000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
305000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
299000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1318000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
534000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
381000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-603000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1909000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-31000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
564000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
291000 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
97000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
602000 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
22000 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
40000 usd
us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
2000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2022000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40000 usd
HCTI Esop Exercised
EsopExercised
10000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1003000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2604000 usd
HCTI Increase In Paycheck Protection Program Loan
IncreaseInPaycheckProtectionProgramLoan
1069000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1013000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3673000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-407000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
147000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1770000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1403000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1363000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1550000 usd
us-gaap Interest Expense
InterestExpense
74000 usd
us-gaap Interest Expense
InterestExpense
259000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
22000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000 usd
us-gaap Business Combination Price Of Acquisition Expected
BusinessCombinationPriceOfAcquisitionExpected
7700000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11588000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-404000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
305000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z01dESX9wUFb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zho3GTqzcLb7">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements is in conformity with GAAP which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the standalone selling price for each distinct performance obligation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the determination of the period of benefit for amortization of deferred costs</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">•</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair value of assets acquired, and liabilities assumed for business combinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">• Share based compensation including warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10050000 usd
CY2022Q2 HCTI Changes Amount
ChangesAmount
1538000 usd
CY2022Q2 HCTI Changes Percentage
ChangesPercentage
0.15 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22644000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18003000 usd
HCTI Changes Amount
ChangesAmount
4641000 usd
HCTI Changes Percentage
ChangesPercentage
0.26 pure
CY2022Q2 HCTI Total Segment Operating Profit
TotalSegmentOperatingProfit
751000 usd
CY2021Q2 HCTI Total Segment Operating Profit
TotalSegmentOperatingProfit
2136000 usd
CY2022Q2 HCTI Total Segment Operating Profit Amount Changes
TotalSegmentOperatingProfitAmountChanges
-1385000 usd
CY2022Q2 HCTI Total Segment Operating Profit Percentage Changes
TotalSegmentOperatingProfitPercentageChanges
-0.65 pure
CY2022Q2 HCTI Unallocated Costs
UnallocatedCosts
2184000 usd
CY2021Q2 HCTI Unallocated Costs
UnallocatedCosts
1667000 usd
CY2022Q2 HCTI Less Unallocated Costs Amount Changes
LessUnallocatedCostsAmountChanges
-517000 usd
CY2022Q2 HCTI Less Unallocated Costs Percentage Changes
LessUnallocatedCostsPercentageChanges
-0.31 pure
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1433000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
469000 usd
CY2022Q2 HCTI Income From Operations Amount Changes
IncomeFromOperationsAmountChanges
-1902000 usd
CY2022Q2 HCTI Income From Operations Percentage Changes
IncomeFromOperationsPercentageChanges
-4.06 pure
CY2022Q2 us-gaap Other Income
OtherIncome
1087000 usd
CY2022Q2 HCTI Other Income Amount Changes
OtherIncomeAmountChanges
1087000 usd
CY2022Q2 HCTI Other Income Percentage Changes
OtherIncomePercentageChanges
1 pure
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
58000 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
164000 usd
CY2022Q2 HCTI Interest Expense Amount Changes
InterestExpenseAmountChanges
106000 usd
CY2022Q2 HCTI Interest Expense Percentage Changes
InterestExpensePercentageChanges
0.65 pure
CY2022Q2 HCTI Net Income Loss Before Income Tax Expenses Amount Changes
NetIncomeLossBeforeIncomeTaxExpensesAmountChanges
-709000 usd
CY2022Q2 HCTI Net Income Loss Before Income Tax Expenses Percentage Changes
NetIncomeLossBeforeIncomeTaxExpensesPercentageChanges
-2.32 pure
us-gaap Business Development
BusinessDevelopment
302000 usd
HCTI Total Segment Operating Profit
TotalSegmentOperatingProfit
1233000 usd
HCTI Total Segment Operating Profit
TotalSegmentOperatingProfit
3223000 usd
HCTI Total Segment Operating Profit Amount Changes
TotalSegmentOperatingProfitAmountChanges
-1990000 usd
HCTI Total Segment Operating Profit Percentage Changes
TotalSegmentOperatingProfitPercentageChanges
-0.62 pure
HCTI Unallocated Costs
UnallocatedCosts
4640000 usd
HCTI Unallocated Costs
UnallocatedCosts
3472000 usd
HCTI Less Unallocated Costs Amount Changes
LessUnallocatedCostsAmountChanges
-1169000 usd
HCTI Less Unallocated Costs Percentage Changes
LessUnallocatedCostsPercentageChanges
-0.34 pure
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3407000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-248000 usd
HCTI Income From Operations Amount Changes
IncomeFromOperationsAmountChanges
-3159000 usd
HCTI Income From Operations Percentage Changes
IncomeFromOperationsPercentageChanges
-12.74 pure
us-gaap Other Income
OtherIncome
1087000 usd
HCTI Other Income Amount Changes
OtherIncomeAmountChanges
1087000 usd
HCTI Other Income Percentage Changes
OtherIncomePercentageChanges
1 pure
us-gaap Interest Expense Debt
InterestExpenseDebt
74000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
259000 usd
HCTI Interest Expense Amount Changes
InterestExpenseAmountChanges
185000 usd
HCTI Interest Expense Percentage Changes
InterestExpensePercentageChanges
0.71 pure
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2394000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-507000 usd
HCTI Net Income Loss Before Income Tax Expenses Amount Changes
NetIncomeLossBeforeIncomeTaxExpensesAmountChanges
-1887000 usd
HCTI Net Income Loss Before Income Tax Expenses Percentage Changes
NetIncomeLossBeforeIncomeTaxExpensesPercentageChanges
-3.72 pure
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-405000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
304000 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
6547000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
9672000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11588000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10050000 usd
CY2022Q2 HCTI Changes Amount
ChangesAmount
1538000 usd
CY2022Q2 HCTI Changes Percentage
ChangesPercentage
0.15 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22644000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18003000 usd
HCTI Changes Amount
ChangesAmount
4641000 usd
HCTI Changes Percentage
ChangesPercentage
0.26 pure
CY2022Q2 us-gaap Revenues
Revenues
11588000 usd
CY2021Q2 us-gaap Revenues
Revenues
10050000 usd
us-gaap Revenues
Revenues
22644000 usd
us-gaap Revenues
Revenues
18003000 usd
CY2022Q2 HCTI Asset Acquisitions Contingent Consideration Liability
AssetAcquisitionsContingentConsiderationLiability
2227000 usd
CY2022Q2 HCTI Weighted Average Shares Outstanding Used In Basic Per Common Share Computations
WeightedAverageSharesOutstandingUsedInBasicPerCommonShareComputations
35507184 shares
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
2201000 usd
us-gaap Business Development
BusinessDevelopment
262000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
2201000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
2201000 usd
CY2021Q2 HCTI Weighted Average Shares Outstanding Used In Basic Per Common Share Computations
WeightedAverageSharesOutstandingUsedInBasicPerCommonShareComputations
28579405 shares
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.011
CY2022Q2 HCTI Warrant Liabilities
WarrantLiabilities
55000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zjotRXdAkjd6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zXMfSyjiXQri">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade receivables. Credit risks associated with trade receivables is minimal due to the Company’s customer base which consist of large customer base and ongoing procedures, which monitor the credit worthiness of its customers. For the quarter ended June 30, 2022 and 2021 sales to top five customers accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zfQd3To8wCJh" title="Concentration Risk, Percentage">73</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20210630__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zjwl9lUNgnPk" title="Concentration Risk, Percentage">85</span>% of total revenue respectively accounts receivable from five major customers accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_ztLUr3zi2E3h" title="Concentration Risk, Percentage">67</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20210630__srt--MajorCustomersAxis__custom--FiveMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zH2yvSGkUpQc" title="Concentration Risk, Percentage">73</span>% of the total accounts receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances in various financial institutions. The balances are generally insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20220630_z7VnhgwSyykb" title="Cash, FDIC Insured Amount">250</span> (valid through June 30, 2022) per institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022 and December 31, 2021, the Company had $<span id="xdx_902_eus-gaap--CashEquivalentsAtCarryingValue_c20220630_pn3n3" title="Cash Equivalents, at Carrying Value">737</span> and $<span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_c20211231_pn3n3" title="Cash Equivalents, at Carrying Value">719</span> respectively, of uninsured cash balances. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash</span></p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
737000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
719000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74000 usd
us-gaap Depreciation
Depreciation
8000 usd
us-gaap Depreciation
Depreciation
5000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15194000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13194000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4189000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2736000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11005000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10458000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
793000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
206000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.011
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.011
CY2022Q2 HCTI Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
86000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
1110000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
2201000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
1100000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11005000 usd
CY2022Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
48000 usd
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
54000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
176000 usd
HCTI Additions Lease Expense
AdditionsLeaseExpense
344000 usd
HCTI Finance Cost Accrued During Year
FinanceCostAccruedDuringYear
6000 usd
HCTI Finance Cost Accrued During Year
FinanceCostAccruedDuringYear
13000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
96000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
181000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
86000 usd
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
176000 usd
HCTI Schedule Of Balance Sheet Releated To Leases Table Textblock
ScheduleOfBalanceSheetReleatedToLeasesTableTextblock
<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfBalanceSheetReleatedToLeasesTableTextblock_pn3n3_zn6xwSbyeDj5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zpfL29rR7fz4">Schedule of balance sheet related to leases</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_493_20220630_z4qhbEqYlFsd" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Months Ended June 30, 2022</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--OperatingLeaseRightOfUseAssets_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease liabilities, included in current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lease liabilities, included in long-term liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1223">—</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zoqYqbImA3Y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
86000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
86000 usd
HCTI Estimated Fair Value Of Common Stock Warrant
EstimatedFairValueOfCommonStockWarrant
1.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.40
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y
CY2022Q2 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
43000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
344000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0475 pure
HCTI Operating Leases Future Minimum Payment Due Current
OperatingLeasesFutureMinimumPaymentDueCurrent
90000 usd
HCTI Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
90000 usd
HCTI Amount Representing Interest
AmountRepresentingInterest
-4000 usd
HCTI Total Lease Obligation
TotalLeaseObligation
86000 usd
CY2022Q2 us-gaap Due From Other Related Parties Noncurrent
DueFromOtherRelatedPartiesNoncurrent
261000 usd
CY2021Q2 us-gaap Due From Other Related Parties Noncurrent
DueFromOtherRelatedPartiesNoncurrent
301000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
43000 usd
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
54000 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
1350000 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
816000 usd
us-gaap Proceeds From Sale Of Other Assets1
ProceedsFromSaleOfOtherAssets1
4500000 usd
HCTI Weighted Average Price Of Stock Amount
WeightedAveragePriceOfStockAmount
700000 usd
HCTI Unvested Common Stock
UnvestedCommonStock
83718 shares
HCTI Earnout Payment
EarnoutPayment
2500000 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2209000 usd
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-04-30
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1709000 usd
CY2022Q2 us-gaap Goodwill Gross
GoodwillGross
1289000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
6018000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
1289000 usd
CY2022Q2 us-gaap Cash
Cash
970000 usd
CY2022Q2 HCTI Business Combination Acquisition Accounts Receivables
BusinessCombinationAcquisitionAccountsReceivables
3142000 usd
CY2022Q2 HCTI Business Combination Acquisition Other Assets Current
BusinessCombinationAcquisitionOtherAssetsCurrent
11419000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
758000 usd
CY2022Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
2209000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
679000 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
3646000 usd
CY2022Q2 HCTI Net Working Capital Acquired
NetWorkingCapitalAcquired
7773000 usd
CY2022Q2 HCTI Total Business Acquisitions Purchase Price
TotalBusinessAcquisitionsPurchasePrice
7773000 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
4244000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
0 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
107000 usd
CY2022Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.88
us-gaap Other Income
OtherIncome
1087000 usd
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
1 pure
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
3212000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
55000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1372000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1445000 usd
CY2022Q2 HCTI Stockbased Compensation
StockbasedCompensation
-7000 usd
CY2021Q4 HCTI Stockbased Compensation
StockbasedCompensation
-18000 usd
CY2022Q2 HCTI Other Income Loan Forgiveness
OtherIncomeLoanForgiveness
293000 usd
CY2021Q4 HCTI Fair Value Of Warrant
FairValueOfWarrant
-15000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1658000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1412000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1658000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1412000 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000 usd
HCTI Total Income Expenses Benefit
TotalIncomeExpensesBenefit
1000 usd
HCTI Total Income Expenses Benefit
TotalIncomeExpensesBenefit
1000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.011
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4000000 shares
CY2021 HCTI Incentive Stock Options Iso
IncentiveStockOptionsIso
1131500 shares
CY2021 HCTI Nonqualified Stock Options Nso
NonqualifiedStockOptionsNso
452000 shares
CY2021 HCTI Nonqualified Stock Options Nso Directors Stock Options
NonqualifiedStockOptionsNsoDirectorsStockOptions
230000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1813500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2186500 shares
CY2022Q1 HCTI Transferred Back To Plan
TransferredBackToPlan
-157927 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2028573 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1971427 shares
CY2022Q2 HCTI Transferred Back To Plan
TransferredBackToPlan
-105208 shares
CY2022Q2 HCTI Transferred Back To Plan
TransferredBackToPlan
-105208 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1866219 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2133781 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q2 us-gaap Share Price
SharePrice
1.066
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.065
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5888183000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2000000 usd

Files In Submission

Name View Source Status
0001607062-22-000489-index-headers.html Edgar Link pending
0001607062-22-000489-index.html Edgar Link pending
0001607062-22-000489.txt Edgar Link pending
0001607062-22-000489-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hcti-20220630.xsd Edgar Link pending
hcti063022form10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hcti-20220630_def.xml Edgar Link unprocessable
hcti-20220630_lab.xml Edgar Link unprocessable
hcti-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hcti-20220630_pre.xml Edgar Link unprocessable
hcti063022form10q_htm.xml Edgar Link completed